Denali Therapeutics DNLI
NASDAQ DNLI
$20.53 -0.14 (-0.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Return on Assets [ROA] (2018 - 2026)

Updated

Denali Therapeutics' Return on Assets [ROA] was -42.19% in Q2 2026, down 2.89 percentage points from -39.30% a year earlier and down 0.06 percentage points from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Denali Therapeutics came in at -40.69%, down 7.25 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of -47.29 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -33.45% in FY2024 (-22.34 pp), -11.11% in FY2023 (+11.65 pp), -22.76% in FY2022 (-3.44 pp) and -19.32% in FY2021 (-25.91 pp).
  • Quarterly Return on Assets [ROA] has moved between -46.58% (Q4 2025) and 2.00% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has declined for nine straight quarters, with an average year-over-year change of -14.57 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2021 (a gain of 28.52 percentage points); the worst was Q3 2022 (a drop of 26.11 percentage points).
  • Per Business Quant data, DNLI's Return on Assets [ROA] in the three quarters before Q2 2026 was -42.14% (Q1 2026), -46.58% (Q4 2025) and -44.89% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Denali Therapeutics 3.30 Bn 3.30 Bn 3.51 Mn -42.19%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.19%
Mar 31, 2026 -42.14%
Dec 31, 2025 -46.58%
Sep 30, 2025 -44.89%
Jun 30, 2025 -39.30%
Mar 31, 2025 -34.31%
Dec 31, 2024 -29.89%
Sep 30, 2024 -28.92%
Jun 30, 2024 -27.22%
Mar 31, 2024 -10.04%
Dec 31, 2023 -12.15%
Sep 30, 2023 -9.79%
Jun 30, 2023 -9.46%
Mar 31, 2023 -25.83%
Dec 31, 2022 -24.35%
Sep 30, 2022 -24.11%
Jun 30, 2022 -21.82%
Mar 31, 2022 -21.07%
Dec 31, 2021 -20.36%
Sep 30, 2021 2.00%
API Access

Denali Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DNLI&period=max&api_key=YOUR_API_KEY